High Flow Nasal Oxygen Therapy an Implementation Study in Pediatric Wards

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-5
SponsorEpicentre

About this trial

The purpose of this study is to prospectively evaluate the process of implementing HFNO in several MSF projects, varying according to geographical and programmatic contexts, population, health structures, human resources, and management. It will generate evidence on the operational feasibility (in terms of human resources, equipment, logistics and costs) of integrating HFNO into PICU standard of care, as well as on the users' and caregivers' perspectives on HFNO and on the children clinical outcomes observed where HFNO is implemented. This relevant information will guide MSF in the decision making of scaling up HFNO therapy in its projects.

Eligibility criteria

Qualifiers

prescription of HFNO by clinician

parent consenting to the use of the data

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

960 Participants
are grouped into 1 trial group

Sponsors and collaborators

Epicentre

Lead sponsor

MOH Afghanistan

Collaborator

MOH Bangladesh

Collaborator

MOH Sierra Leone

Collaborator

MOH Yemen

Collaborator

MSF Médecins Sans Frontières Belgium

Collaborator

MSF Médecins Sans Frontières France

Collaborator

Fisher and Paykel Healthcare

Collaborator